• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来源于 的可溶性多糖通过调节肠道微生物群缓解肥胖相关的非酒精性脂肪性肝病。

Soluble Polysaccharide Derived from Attenuates Obesity-Related Nonalcoholic Fatty Liver Disease Associated with Gut Microbiota Regulation.

机构信息

Third Institute of Oceanography, Ministry of Natural Resources, Xiamen 361005, China.

Technical Innovation Center for Exploitation of Marine Biological Resources, Ministry of Natural Resources, Xiamen 361005, China.

出版信息

Mar Drugs. 2021 Dec 9;19(12):699. doi: 10.3390/md19120699.

DOI:10.3390/md19120699
PMID:34940698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8706399/
Abstract

In this study, the effects of a polysaccharide derived from (LJP) on obesity were investigated in mice fed a high-fat diet (HFD). LJP significantly attenuated obesity-related features, lowering serum triglycerides, glucose, total cholesterol and low-density lipoprotein cholesterol levels. HFD-induced liver steatosis and hepatocellular ballooning were significantly attenuated by LJP. Additionally, LJP was found to significantly modulate hepatic gene expressions of AMPK and HMGCR, which are key regulators of lipid and cholesterol metabolism. We further found that LJP ameliorated HFD-induced gut microbiota (GM) dysbiosis by significantly reducing the obesity-related Firmicutes to Bacteroidetes ratio, meanwhile promoting the growth of Verrucomicrobia at the phylum level. At the genus level, propionate-producing bacteria and were elevated by LJP, which might explain the result that LJP elevated fecal propionate concentration. Taken together, these findings suggest that dietary intake of LJP modulates hepatic energy homeostasis to alleviate obesity-related nonalcoholic fatty liver disease associated with GM regulation.

摘要

在这项研究中,研究了来源于(LJP)的多糖对高脂饮食(HFD)喂养小鼠肥胖的影响。LJP 显著减轻了肥胖相关特征,降低了血清甘油三酯、葡萄糖、总胆固醇和低密度脂蛋白胆固醇水平。LJP 显著减轻了 HFD 诱导的肝脂肪变性和肝细胞气球样变。此外,研究发现 LJP 显著调节了肝脏 AMPK 和 HMGCR 的基因表达,这是脂质和胆固醇代谢的关键调节因子。我们进一步发现,LJP 通过显著降低肥胖相关的厚壁菌门到拟杆菌门的比例,同时促进疣微菌门在门水平上的生长,改善了 HFD 诱导的肠道微生物群(GM)失调。在属水平上,LJP 增加了产生丙酸盐的细菌和,这可能解释了 LJP 提高粪便丙酸盐浓度的结果。总之,这些发现表明,饮食摄入 LJP 可调节肝脏能量稳态,减轻与 GM 调节相关的肥胖相关非酒精性脂肪性肝病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf6/8706399/3f7cfb87fdb6/marinedrugs-19-00699-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf6/8706399/682403078fa1/marinedrugs-19-00699-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf6/8706399/95a05f665f7e/marinedrugs-19-00699-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf6/8706399/ce4e61f1ff12/marinedrugs-19-00699-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf6/8706399/bf0534dc5261/marinedrugs-19-00699-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf6/8706399/a324627029ec/marinedrugs-19-00699-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf6/8706399/001f14501865/marinedrugs-19-00699-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf6/8706399/b74ddcd1324f/marinedrugs-19-00699-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf6/8706399/c098bb9f3491/marinedrugs-19-00699-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf6/8706399/3f7cfb87fdb6/marinedrugs-19-00699-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf6/8706399/682403078fa1/marinedrugs-19-00699-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf6/8706399/95a05f665f7e/marinedrugs-19-00699-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf6/8706399/ce4e61f1ff12/marinedrugs-19-00699-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf6/8706399/bf0534dc5261/marinedrugs-19-00699-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf6/8706399/a324627029ec/marinedrugs-19-00699-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf6/8706399/001f14501865/marinedrugs-19-00699-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf6/8706399/b74ddcd1324f/marinedrugs-19-00699-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf6/8706399/c098bb9f3491/marinedrugs-19-00699-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eaf6/8706399/3f7cfb87fdb6/marinedrugs-19-00699-g009.jpg

相似文献

1
Soluble Polysaccharide Derived from Attenuates Obesity-Related Nonalcoholic Fatty Liver Disease Associated with Gut Microbiota Regulation.来源于 的可溶性多糖通过调节肠道微生物群缓解肥胖相关的非酒精性脂肪性肝病。
Mar Drugs. 2021 Dec 9;19(12):699. doi: 10.3390/md19120699.
2
Effects of sulfated polysaccharides from Laminaria japonica on regularating the gut microbiotan and alleviating intestinal inflammation in obese mice.海带硫酸多糖对肥胖小鼠肠道微生物群的调节作用及缓解肠道炎症。
Food Chem Toxicol. 2022 Oct;168:113401. doi: 10.1016/j.fct.2022.113401. Epub 2022 Sep 3.
3
Insoluble dietary fiber derived from brown seaweed Laminaria japonica ameliorate obesity-related features via modulating gut microbiota dysbiosis in high-fat diet-fed mice.褐藻来源的不可溶性膳食纤维通过调节高脂肪饮食喂养小鼠的肠道菌群失调改善肥胖相关特征。
Food Funct. 2021 Jan 21;12(2):587-601. doi: 10.1039/d0fo02380a. Epub 2020 Dec 22.
4
Saccharina Japonica Polysaccharides Suppress High-Fat Diet-Induced Obesity and Modulate Gut Microbiota Composition and Function.裙带菜多糖抑制高脂饮食诱导的肥胖,并调节肠道微生物群落组成和功能。
Chem Biodivers. 2024 Aug;21(8):e202401088. doi: 10.1002/cbdv.202401088. Epub 2024 Jul 23.
5
Seabuckthorn polysaccharide ameliorates high-fat diet-induced obesity by gut microbiota-SCFAs-liver axis.沙棘多糖通过肠道微生物群-SCFAs-肝脏轴改善高脂饮食诱导的肥胖。
Food Funct. 2022 Mar 7;13(5):2925-2937. doi: 10.1039/d1fo03147c.
6
Laminaria japonica polysaccharide prevents high-fat-diet-induced insulin resistance in mice via regulating gut microbiota.海带多糖通过调节肠道微生物群预防高脂肪饮食诱导的小鼠胰岛素抵抗。
Food Funct. 2021 Jun 21;12(12):5260-5273. doi: 10.1039/d0fo02100h. Epub 2021 May 17.
7
The polyherbal drug GGEx18 from Laminaria japonica, Rheum palmatum, and Ephedra sinica inhibits hepatic steatosis and fibroinflammtion in high-fat diet-induced obese mice.来自海带、大黄和麻黄的复方草药药物 GGEx18 可抑制高脂肪饮食诱导的肥胖小鼠的肝脂肪变性和纤维炎症。
J Ethnopharmacol. 2018 Oct 28;225:31-41. doi: 10.1016/j.jep.2018.06.034. Epub 2018 Jun 26.
8
Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.槲皮素对高脂饮食诱导的小鼠非酒精性脂肪性肝病的保护作用是通过调节肠道微生物群失衡和相关肠-肝轴激活来介导的。
Free Radic Biol Med. 2017 Jan;102:188-202. doi: 10.1016/j.freeradbiomed.2016.11.037. Epub 2016 Nov 25.
9
Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis.用白藜芦醇靶向肠道微生物群:管理肝脂肪变性的新证据的例证。
J Nutr Biochem. 2020 Jul;81:108363. doi: 10.1016/j.jnutbio.2020.108363. Epub 2020 Feb 27.
10
Anti-obesity effects of fucoidan in high-fat diet-fed mice vary with the gut microbiota structure.褐藻糖胶在高脂饮食喂养的小鼠中的抗肥胖作用因肠道微生物结构的不同而不同。
Food Funct. 2022 Jun 6;13(11):6259-6270. doi: 10.1039/d2fo00480a.

引用本文的文献

1
In Vitro Digestion and Gut Microbiota Fermentation of the Anticancer Marine Drug BG136: Stability and Biotransformation Investigation.抗癌海洋药物BG136的体外消化及肠道微生物群发酵:稳定性与生物转化研究
Mar Drugs. 2025 Apr 3;23(4):156. doi: 10.3390/md23040156.
2
The impact of traditional Chinese medicine and dietary compounds on modulating gut microbiota in hepatic fibrosis: A review.中药和膳食化合物对肝纤维化中肠道微生物群调节作用的研究综述
Heliyon. 2024 Sep 26;10(19):e38339. doi: 10.1016/j.heliyon.2024.e38339. eCollection 2024 Oct 15.
3
Interactions between Gut Microbiota and Natural Bioactive Polysaccharides in Metabolic Diseases: Review.

本文引用的文献

1
Low-molecular alginate improved diet-induced obesity and metabolic syndrome through modulating the gut microbiota in BALB/c mice.低分子褐藻酸钠通过调节 BALB/c 小鼠肠道微生物群改善饮食诱导的肥胖和代谢综合征。
Int J Biol Macromol. 2021 Sep 30;187:811-820. doi: 10.1016/j.ijbiomac.2021.08.003. Epub 2021 Aug 4.
2
Laminaria japonica polysaccharide prevents high-fat-diet-induced insulin resistance in mice via regulating gut microbiota.海带多糖通过调节肠道微生物群预防高脂肪饮食诱导的小鼠胰岛素抵抗。
Food Funct. 2021 Jun 21;12(12):5260-5273. doi: 10.1039/d0fo02100h. Epub 2021 May 17.
3
Medicinal plants from the 14 edition of the Russian Pharmacopoeia, recent updates.
肠道微生物群与代谢性疾病中天然生物活性多糖的相互作用:综述。
Nutrients. 2024 Aug 24;16(17):2838. doi: 10.3390/nu16172838.
4
Protective Effects of Polysaccharide Composite Microcapsules on the Survival of during Simulated Gastrointestinal Digestion and Heat Treatment.多糖复合微胶囊对 模拟胃肠道消化和热处理过程中生存的保护作用。
Mar Drugs. 2024 Jun 30;22(7):308. doi: 10.3390/md22070308.
5
Dual-Stimuli-Responsive Gut Microbiota-Targeting Nitidine Chloride-CS/PT-NPs Improved Metabolic Status in NAFLD.双刺激响应型靶向肠道微生物群的盐酸小檗碱-CS/PT-NPs 改善 NAFLD 患者的代谢状态。
Int J Nanomedicine. 2024 Mar 8;19:2409-2428. doi: 10.2147/IJN.S452194. eCollection 2024.
6
Tibetan tea reduces obesity brought on by a high-fat diet and modulates gut flora in mice.藏茶可减轻高脂饮食诱导的小鼠肥胖,并调节其肠道菌群。
Food Sci Nutr. 2023 Aug 7;11(10):6582-6595. doi: 10.1002/fsn3.3607. eCollection 2023 Oct.
7
Effect of Probiotic-Fortified Infant Formula on Infant Gut Health and Microbiota Modulation.益生菌强化婴儿配方奶粉对婴儿肠道健康和微生物群调节的影响。
Food Sci Anim Resour. 2023 Jul;43(4):659-673. doi: 10.5851/kosfa.2023.e26. Epub 2023 Jul 1.
8
Intestinal flora: A new target for traditional Chinese medicine to improve lipid metabolism disorders.肠道菌群:中药改善脂质代谢紊乱的新靶点。
Front Pharmacol. 2023 Mar 1;14:1134430. doi: 10.3389/fphar.2023.1134430. eCollection 2023.
9
The interaction between dietary fiber and gut microbiota, and its effect on pig intestinal health.膳食纤维与肠道微生物群的相互作用及其对猪肠道健康的影响。
Front Immunol. 2023 Feb 14;14:1095740. doi: 10.3389/fimmu.2023.1095740. eCollection 2023.
10
Metagenomic Insights into the Anti-Obesity Effect of a Polysaccharide from .宏基因组学对来自……的一种多糖抗肥胖作用的见解 。 你提供的原文似乎不完整,“from”后面缺少具体内容。
Foods. 2023 Feb 3;12(3):665. doi: 10.3390/foods12030665.
俄罗斯药典第 14 版中的药用植物,最新更新。
J Ethnopharmacol. 2021 Mar 25;268:113685. doi: 10.1016/j.jep.2020.113685. Epub 2020 Dec 11.
4
Pharmacokinetics of Marine-Derived Drugs.海洋来源药物的药代动力学。
Mar Drugs. 2020 Nov 9;18(11):557. doi: 10.3390/md18110557.
5
The protective mechanisms of macroalgae Laminaria japonica consumption against lipid metabolism disorders in high-fat diet-induced hyperlipidemic rats.海带摄入对高脂饮食诱导的高血脂大鼠脂代谢紊乱的保护机制。
Food Funct. 2020 Apr 30;11(4):3256-3270. doi: 10.1039/d0fo00065e.
6
Enzymatic preparation of a low-molecular-weight polysaccharide rich in uronic acid from the seaweed Laminaria japonica and evaluation of its hypolipidemic effect in mice.从海藻海带中酶法制备富含糖醛酸的低分子量多糖及其降脂作用的研究。
Food Funct. 2020 Mar 26;11(3):2395-2405. doi: 10.1039/c9fo02994j.
7
Determination of fucoidan in rat plasma by HPLC and its application in pharmacokinetics.用高效液相色谱法测定大鼠血浆中岩藻依聚糖及其在药代动力学中的应用。
Pak J Pharm Sci. 2020 Jan;33(1):1-9.
8
Propionate promotes intestinal lipolysis and metabolic benefits via AMPK/LSD1 pathway in mice.丙酸酯通过AMPK/LSD1途径促进小鼠肠道脂肪分解及代谢益处。
J Endocrinol. 2019 Dec;243(3):187-197. doi: 10.1530/JOE-19-0188.
9
Propionate suppresses hepatic gluconeogenesis via GPR43/AMPK signaling pathway.丙酸通过 GPR43/AMPK 信号通路抑制肝糖异生。
Arch Biochem Biophys. 2019 Sep 15;672:108057. doi: 10.1016/j.abb.2019.07.022. Epub 2019 Jul 26.
10
Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases.短链脂肪酸(SCFAs)介导的肠道上皮和免疫调节及其对炎症性肠病的相关性。
Front Immunol. 2019 Mar 11;10:277. doi: 10.3389/fimmu.2019.00277. eCollection 2019.